Trial site
Medical Corporation Heishinkai OCROM Clinic
- 8running trials
- 7closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Obesity9 trials
- Type 2 diabetes8 trials
- Alzheimer disease2 trials
- Diabetic neuropathy1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 312 trials
- Phase 23 trials
- Status
- Active, not recruiting6 trials
- Completed6 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Eli Lilly and Company15 trials
Running trials
Recruiting
Recruiting
Active, not recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Recruiting
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
Withdrawn
Completed
A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
Completed
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Site data: ClinicalTrials.govUpdated 19 Nov 2026